Advertisement

Topics

News about Biotechnology, Pharmaceutical and Healthcare

11:14 EDT 20th September 2018 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 14,000+

Thursday 20th September 2018

Aucta and Catalent enter commercial supply agreement

Aucta and Catalent entered a commercial supply agreement for vigabatrin to employ Catalentâs dosage new drug packaging technology.

Talks between Boots and PDA Union end without agreement

Talks between Boots and the Pharmacists’ Defence Association Union over the future representation of Boots pharmacists have ended without agreement.

Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD

Kalytera Therapeutics, Inc. (TSXV:KALY, OTCQB:KALTF) (the "Company" or "Kalytera") today provided an update on its lead product development program evaluating cannabidiol (“CBD”) for the prevention and treatment of acute graft versus host disease (“GVHD”). The post Kalytera Therapeutics Provides Update for Lead Program in Prevention and Treatment of GVHD appeared first on Investing News Ne...

Medtronic secures FDA approval for revised labeling of CoreValve Evolut TAVR system

The US regulator approved an investigational device exemption (IDE) to start a single-arm study to evaluate the CoreValve Evolut TAVR system in patients with bicuspid aortic valves who The post Medtronic secures FDA approval for revised labeling of CoreValve Evolut TAVR system appeared first on Compelo Medical Devices.

Study shows new computer program can analyze images of patients’ lung tumors

The study found that a type of artificial intelligence (AI), or machine learning program, could distinguish with 97% accuracy between adenocarcinoma and squamous cell carcinoma. In the study, The post Study shows new computer program can analyze images of patients’ lung tumors appeared first on Compelo Medical Devices.

Quadrant Biosciences secures NIH grant for novel autism spectrum disorder diagnostic assay

This collaborative award follows the company’s successful Phase I findings and will support the ongoing work of investigators Frank Middleton, PhD. at SUNY Upstate Medical University, Steven Hicks, The post Quadrant Biosciences secures NIH grant for novel autism spectrum disorder diagnostic assay appeared first on Compelo Medical Devices.

Allergan to construct medical aesthetics innovation center in Chengdu, China

The new center, which will be constructed at the High-Tech Zone of Chengdu, is expected to be opened in early 2019. Allergan has signed the cooperation agreement with The post Allergan to construct medical aesthetics innovation center in Chengdu, China appeared first on Compelo Medical Devices.

Canntab Sets New All-Time High Trading Prices and Volume

Canntab Therapeutics (CSE:PILL) ("Canntab" or the "Company"), a leader in the development of the cannabis in tablet or capsule form, is pleased to announce that the Company's common shares ("Common Shares") yesterday reached new all-time daily high and closing prices of $1.74 and $1.41, respectively, on the Canadian Securities Exchange (the "CSE"). The post Canntab Sets New All-Time High Trading P...

Majority of US consumers would be willing to buy prescription drugs through Amazon

Over 70% of Amazon customers in the United States would be willing to buy prescription drugs through the online retailer, according to the results of a survey carried out by Deutsche Bank. 

MMR vaccine coverage in England falls for fourth year in a row

Childhood vaccination coverage declined in 9 of the 12 routine vaccinations measured at ages one, two or five years in 2017/2018, compared with the previous year, according to statistics released by Public Health England.

Double win for BNF app at the British Interactive Media Awards

The British National Formulary app, launched by Pharmaceutical Press in July 2017, has won two prizes at the 2018 British Interactive Media Awards.

New Insight Into Aging

NewsResearchers at the Montreal Neurological Institute and Hospital (The Neuro) of McGill University examined the effects of aging on neuroplasticity in the primary auditory cortex.

UT Engineers Develop First Method for Controlling Nanomotors

NewsBreakthrough for nanotechnology as UT engineers develop first method for switching the mechanical motion of nanomotors.Contributed Author:

Mineral Weathering From Thawing Permafrost can Release Substantial Carbon Dioxide

NewsNew research from UAlberta ecologists shows mineral weathering can be a significant contributor to Arctic climate change.Contrib

Astellas' chronic kidney cancer drug shows superiority at Phase 3 http://bit.ly/2PS9xHB  #oncology #cancer #Astellas

Astellas' chronic kidney cancer drug shows superiority at Phase 3 http://bit.ly/2PS9xHB  #oncology #cancer #Astellas

Shares in Molecular Templates surge after the announcement of Takeda collaboration http://bit.ly/2QQN53c  @Moltemp #Takeda #StockMarket #pharmapic.twitter.com/YRDKoitfNh

Shares in Molecular Templates surge after the announcement of Takeda collaboration http://bit.ly/2QQN53c  @Moltemp #Takeda #StockMarket #pharma

Active Temperature Control for Flow Chemistry in Glass Chip Reactors

Uniqsis has introduced the Polar Bear Plus GSM™ - a versatile heating and cooling reactor module for flow chemistry applications using Glass Static Mixers / Reactor Chips (GSMs). To achieve high reproducibility and facilitate scale-up the control of mixing and temperature is essential, particularly for highly exothermic or fast, mixing-dependent reactions. Uniqsis glass static mixer / reacto...

MSD to launch Keytruda at half US list price in China http://bit.ly/2DdUMNR  #Keytruda #China #Cancer #globalmarkets #pharmapic.twitter.com/ufU2VAUydV

MSD to launch Keytruda at half US list price in China http://bit.ly/2DdUMNR  #Keytruda #China #Cancer #globalmarkets #pharma pic.tw

FDA greenlights Teva's migraine drug Ajovy in two dosage options http://bit.ly/2poE9ph  #Teva #Ajovy #FDApic.twitter.com/TeOgTy9djK

FDA greenlights Teva's migraine drug Ajovy in two dosage options http://bit.ly/2poE9ph  #Teva #Ajovy #FDA pic.twitter.com/TeOgTy9djK

Senate bill would save money and allow generics to reach market more quickly, according to CBO report http://bit.ly/2xA1w2E  #USPolitics #biosimilars #generics #pharmapic.twitter.com/SxAZXg9MgY

Senate bill would save money and allow generics to reach market more quickly, according to CBO report http://bit.ly/2xA1w2E  #USPolitics #biosimilars #generics #pharma pic.twitter.com/SxAZXg9MgY

WCOR secures CE certification for blood sugar trend monitoring device

The Certification confirms that the Helo Extense device is considered safe and a low risk device when used as intended. The Company is in the process of completing The post WCOR secures CE certification for blood sugar trend monitoring device appeared first on Compelo Medical Devices.

Cardiac Dimensions starts clinical trial of Carillon mitral contour system

The company randomized its first patient in the US pivotal Carillon trial. The study has been designed to assess the Carillon mitral contour system to treat FMR associated The post Cardiac Dimensions starts clinical trial of Carillon mitral contour system appeared first on Compelo Medical Devices.

IDbyDNA partners with Fleury Group to use Explify platform across South America

Under the agreement, IDbyDNA will license the Explify platform for Fleury’s utilization in high quality clinical metagenomic testing. Fleury labs provides healthcare analysis services across South America, with The post IDbyDNA partners with Fleury Group to use Explify platform across South America appeared first on Compelo Medical Devices.

Shares in Molecular Templates surge after the announcement of Takeda collaboration

Shares in the Texas based biotech Molecular Templates have soared after the company announced that they would be collaborating with Japanese pharma firm Takeda for the joint development of CD38-targeted Engineered Toxin Bodies (ETBs) for the treatment of patients with diseases such as multiple myeloma.  Under the terms of the agreement, Takeda will make an upfront payment of $30 million. Howe...

Emmaus Signs Agreement with Cardinal Health to Solidify Distribution Network for Endari

News Endari (L-glutamine oral powder) is indicated to reduce the acute complications of sickle cell disease in adult and pediatric patients five years of age and older.


Advertisement
Quick Search
Advertisement
Advertisement